Pascal Bamford - Aug 29, 2024 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief Clinical Officer
Signature
/s/ Pascal Bamford by Brian McKelligon, Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Aug 29, 2024
Transactions value $
$0
Form type
4
Date filed
9/3/2024, 09:41 PM
Next filing
Nov 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Award $0 +40K +48.33% $0.00 123K Aug 29, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units shall vest in full on the second anniversary of the first day of the month subsequent to the date of grant.
F2 Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.